Introduction
The Joint Commission on Accreditation of Healthcare Organizations (TJC) requires US hospitals to manage all aspects of medication use throughout the institution. Within its medication management (MM) standards, TJC lists explicit expectations for establishment of policies governing the procurement, storage, labeling, administration, and monitoring of medications. Although conventional hospital pharmacy operational requirements are well described in TJC standards, drug information requirements are less clear.
TJC standards for drug information in hospitals are limited to MM 02.01.01 (formerly MM 2.10) titled ''The hospital selects and procures medications.'' Within this standard, Element of Performance (EP) 9 states ''Medications designated as available for dispensing or administration are reviewed at least annually based on emerging safety and efficacy information.'' 1 A similar statement is also found in the Centers for Medicare and Medicaid Conditions for Participation No. 482.25. This report describes our interpretation of the intent of this standard and subsequent efforts by drug information specialists at our hospital to comply with its requirements.
Methods
In order to satisfy information standards implicit in MM 02.01.01 EP-9, pharmacists at the hospital's Drug Information Center established periodic directed searches of the National Library of Medicine's (NLM's) MEDLINE/PubMed database. Each month, a Boolean PubMed search is performed using the inclusive search term ''drug therapy'' with the following filters activated:
Publication dates: Most recent 30-day period Article type: Randomized controlled trial (RCT) Species: Humans Language: English Journal types: Core clinical journals.
Following a review of the titles and abstracts of identified RCTs, those that present findings judged by the Drug Information Center staff as having the potential to change prescribing patterns or otherwise alter drug use are selected and saved electronically or printed. Selected articles are grouped together and abstracted in a standardized format according to medical specialty. This format includes brief bibliographical annotations of the design, findings, and conclusions of each study. Each quarter, selected abstracts are compiled into a 4-page document titled University of Colorado Hospital/JCAHO 2.01.01 Safety and Efficacy Search Results.
Quarterly abstract compilations are periodically distributed to members of the hospital's Pharmacy and Therapeutics (P&T) Committee at a regularly scheduled meeting. The abstracts are presented along with directives that this is intended to satisfy TJC standards requiring the P&T Committee to regularly review available medications in light of emerging safety and efficacy information.
Quarterly abstract compilations are made available to all hospital employees through inclusion in the hospital intranet. In addition to general departmental, therapeutic policy, medication safety, drug shortage, and formulary information, the Pharmacy Resource Site (MedKeeper Hub TM , MedKeeper, Westminster, Colorado) contains a link to Abstracts of Medical Literature. When selected, this link displays quarterly report listings for the most recent 3 years and archived access listings covering an additional 2 years. These folders are provided as portable data format (PDF) files and, as such, are searchable. Search terms are displayed within each abstract title in bolded font. Searches enable identification of the bibliographical citation and the associated findings of each respective study. Chronologically, recent abstracts include digital object identifier (doi) addresses with active hyperlink access to online articles.
Results and Discussion
Beginning in 2006, findings and conclusions of selected RCTs reported in core clinical journals were abstracted and included in quarterly compilations (see Supplementary Materials) . These were routinely distributed to P&T Committee members and affiliates and posted on the hospital intranet.
In our view, verbiage contained in MM 02.01.01 EP-9 requires identification, review, and dissemination of all clinically relevant emerging or new information on the safety and effectiveness of drug therapy. Given the unprecedented breadth of clinical research now being conducted, attainment of this lofty informational goal is unrealistic. Nonetheless, TJC standards demand that effort must be made to satisfy requirements for regular reviews of medication safety and efficacy information. Decisions concerning how to approach this issue and how to comply with this MM standard are left to the discretion of each individual institution.
Because initial deliberations concerning MM 02.01.01 EP-9 led to conclusions that hospital personnel responsible for decisional review of available medications must be well informed with regard to valid safety and efficacy information, we chose RCTs as our information target. The RCT is currently considered the most accurate measure of drug safety and efficacy, and approval of new drug products or acceptance of new uses of established drugs invariably necessitates RCT verification. We reasoned that RCT data, especially that published in credible biomedical periodicals such as those included among the NLM's core clinical journals, are best suited to decision making. Accordingly, RCT data were selected as the most appropriate type of information to be provided to our P&T Committee.
Interpretation of the information requirements imposed by MM 02.01.01 EP-9 is discordant across the spectrum of hospitals.
A listserv query of University HealthSystem Consortium (UHC)affiliated hospitals posted at the beginning of our project in 2006 revealed that 1 (9%) of 11 respondents routinely performed limited searches of peer-reviewed medical literature for safety and efficacy information. No respondents compiled safety and efficacy data into summary reports. Seven (64%) respondents reported that they routinely relay medication safety information to committee members, practitioners, and staff in the form of newsletters and alerts from the Food and Drug Administration's MedWatch program, the Center for Disease Control's Morbidity and Mortality Weekly Report, and the Institute for Safe Medication Practice's Medication Safety Alert. Although 1 (9%) respondent indicated that the hospital formulary in entirety received a formal vote of P&T Committee approval annually, all others provided information suggesting that routine P&T Committee activities related to addition and deletion of pharmaceuticals from their formulary served to at least tacitly satisfy MM 02.01.01 EP-9 standards.
In conclusion, we have devised a means to address informational review requirements imposed by TJC standards. Directed searches of the medical literature and creation of annotated bibliographical summaries of identified RCT data regarding medication safety and efficacy support informed formulary review.
